Formula: | C18H28N8O |
Molecular Weight: | 372.48 |
Rotatable Bond Donors: | 5 |
clogP: | 0.98 |
Topological Polar Surface Area: | 84.97 |
Lipinski's RO5: | MW: 372.48 HBA: 9 HBD: 0 RB: 5 LogP: 0.98 |
Rule of Three: | MW: 372.48 HBA: 9 HBD: 0 RB: 5 LogP: 0.98 |
|
ECBD ID | Similarity | Structure | SDF |
---|
ECBD ID | Similarity | Structure | SDF | |
---|---|---|---|---|
EOS32639 | 0.7 | EOS32639 RDKit 3D 27 30 0 0 0 0 0 0 0 0999 V2000 5.9153 2.4260 -1.7524 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2842 1.2911 -1.0576 C 0 0 0 0 0 0 0 0 0 0 0 0 3.9094 1.0401 -0.8856 C 0 0 0 0 0 0 0 0 0 0 0 0 3.8218 -0.1409 -0.1728 C 0 0 0 0 0 0 0 0 0 0 0 0 2.6909 -0.9015 0.3069 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8355 -1.9358 0.9587 O 0 0 0 0 0 0 0 0 0 0 0 0 1.4229 -0.4388 0.0317 N 0 0 0 0 0 0 0 0 0 0 0 0 1.0546 0.7501 -0.6962 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4615 0.7327 -0.7775 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.9497 -0.2710 0.2764 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.0686 -1.0534 -0.3389 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.0445 -2.3008 -0.7702 N 0 0 0 0 0 0 0 0 0 0 0 0 -3.2962 -2.5637 -1.2707 N 0 0 0 0 0 0 0 0 0 0 0 0 -4.0851 -1.5058 -1.1567 N 0 0 0 0 0 0 0 0 0 0 0 0 -3.3264 -0.5667 -0.5714 N 0 0 0 0 0 0 0 0 0 0 0 0 -3.8387 0.7417 -0.2645 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.3102 1.4771 -1.5007 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.3281 2.4792 -0.9916 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.7952 1.9817 0.3655 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.0530 0.6878 0.6379 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.3872 0.4285 1.5085 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.7101 -0.5541 2.5409 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3188 1.2411 2.0753 C 0 0 0 0 0 0 0 0 0 0 0 0 0.2699 -1.1911 0.4778 C 0 0 0 0 0 0 0 0 0 0 0 0 5.1284 -0.5070 0.0223 N 0 0 0 0 0 0 0 0 0 0 0 0 5.6067 -1.6881 0.7123 C 0 0 0 0 0 0 0 0 0 0 0 0 6.0338 0.3415 -0.4948 N 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 3 4 2 0 4 5 1 0 5 6 2 0 5 7 1 0 7 8 1 0 8 9 1 0 9 10 1 0 10 11 1 0 11 12 2 0 12 13 1 0 13 14 2 0 14 15 1 0 15 16 1 0 16 17 1 0 17 18 1 0 18 19 1 0 19 20 1 0 10 21 1 0 21 22 1 0 21 23 1 0 10 24 1 0 4 25 1 0 25 26 1 0 25 27 1 0 27 2 2 0 24 7 1 0 15 11 1 0 20 16 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
GPR35 antagonism | primary assay | G-protein coupled receptor 35 | inactive |